Jade Biosciences Inc (JBIO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2017 | 12-2006 | 12-2005 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -9,611 | -3,330 | N/A | N/A | N/A |
| Depreciation Amortization | 1 | N/A | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | 37 | 436 | N/A | N/A | N/A |
| Other Working Capital | 974 | 549 | N/A | N/A | N/A |
| Other Operating Activity | 740 | -436 | 0 | 0 | 0 |
| Operating Cash Flow | $-7,859 | $-2,781 | $N/A | $N/A | $N/A |
| Cash Flows From Investing Activities | |||||
| Investing Cash Flow | $N/A | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | 2,500 | 2,500 | N/A | N/A | N/A |
| Common Stock Issued | 5 | N/A | N/A | N/A | N/A |
| Other Financing Activity | 6,413 | 0 | 0 | 0 | 0 |
| Financing Cash Flow | $8,918 | $2,500 | $N/A | $N/A | $N/A |
| Beginning Cash Position | 3,514 | 3,795 | N/A | N/A | N/A |
| End Cash Position | 4,573 | 3,514 | N/A | N/A | N/A |
| Net Cash Flow | $1,059 | $-281 | $N/A | $N/A | $N/A |
| Free Cash Flow | |||||
| Operating Cash Flow | -7,859 | -2,781 | N/A | N/A | N/A |
| Free Cash Flow | -7,859 | -2,781 | 0 | 0 | 0 |